Foresite Capital Management Vi LLC Centessa Pharmaceuticals PLC Transaction History
Foresite Capital Management Vi LLC
- $224 Billion
- Q4 2024
A detailed history of Foresite Capital Management Vi LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 1,253,379 shares of CNTA stock, worth $21 Million. This represents 9.35% of its overall portfolio holdings.
Number of Shares
1,253,379Holding current value
$21 Million% of portfolio
9.35%Shares
1 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$334 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$167 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$162 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$106 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$97.2 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.58B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...